Abstract
Lung cancer is a global public health concern with the highest morbidity and mortality among all cancers. Biomarkers can be used for early lung cancer detection, prognostication and optimal treatment. Research on biomarkers will enable more effective therapy for each individual patient. Great progress has been made in biomarker discovery with more understanding involved in lung cancer. Lung cancer biomarkers can be classified into Proteins, DNAs, Epigenomics, and RNAs according to their biochemical properties. Here, we will discuss the most common biomarkers for lung cancer.
Keywords: Biomarker, diagnosis, lung cancer, prognosis.
Current Signal Transduction Therapy
Title:Current Biomarkers for Lung Cancer
Volume: 9 Issue: 3
Author(s): Kaifei Wang, Zhaohui Huang, Ruilin Wang, Jin Qian, Zhenhua Zuo, Yaping Li, Xiaoyan Yao and Xizhou Guan
Affiliation:
Keywords: Biomarker, diagnosis, lung cancer, prognosis.
Abstract: Lung cancer is a global public health concern with the highest morbidity and mortality among all cancers. Biomarkers can be used for early lung cancer detection, prognostication and optimal treatment. Research on biomarkers will enable more effective therapy for each individual patient. Great progress has been made in biomarker discovery with more understanding involved in lung cancer. Lung cancer biomarkers can be classified into Proteins, DNAs, Epigenomics, and RNAs according to their biochemical properties. Here, we will discuss the most common biomarkers for lung cancer.
Export Options
About this article
Cite this article as:
Wang Kaifei, Huang Zhaohui, Wang Ruilin, Qian Jin, Zuo Zhenhua, Li Yaping, Yao Xiaoyan and Guan Xizhou, Current Biomarkers for Lung Cancer, Current Signal Transduction Therapy 2014; 9 (3) . https://dx.doi.org/10.2174/1574362409666140911225531
DOI https://dx.doi.org/10.2174/1574362409666140911225531 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
Current Drug Metabolism Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations
Current Genomics Rikkunshito and Ghrelin Secretion
Current Pharmaceutical Design Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets A Review of Chemotherapy and Photodynamic Therapy for Lung Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Recent Patents on Proteasome Inhibitors of Natural Origin
Recent Patents on Anti-Cancer Drug Discovery Transactivation of ErbB Receptors by Leptin in the Cardiovascular System: Mechanisms, Consequences and Target for Therapy
Current Pharmaceutical Design Prognostic Parameters in Myeloid Malignancies in a Historical Context – From Microscopy to Individualized Medicine
Current Drug Targets Targeting SphK1 as a New Strategy against Cancer
Current Drug Targets Characteristics of Brain Tumor Stem Cells and the Rationale for Applying Tyrosine Kinase Inhibitors as Potential Targeting Agents
Recent Patents on Regenerative Medicine In Vitro and In Vivo Evaluation of [99mTc(CO)3]-Radiolabeled ErbB-2-Targeting Peptides for Breast Carcinoma Imaging
Current Radiopharmaceuticals Pharmacodynamic Evaluation of Novel Tetrandrine-loaded Chitosan Microspheres
Letters in Drug Design & Discovery Cellular Senescence in the Development and Treatment of Cancer
Current Pharmaceutical Design Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
Current Genomics Editorial [Targeting Genetic Instability in Cancer Cells (Guest Editor: Francesco Colotta)]
Current Drug Targets Editorial [Hot topic: Contemporary Approaches in Cancer Therapy (Guest Editor: Riyaz Basha)]
Medicinal Chemistry Editorial (Thematic Issue: Chronic Myeloid Leukemia: Reaching For the Cure)
Current Cancer Drug Targets Apoptosis Suppression by Candidate Oncogene PLAC8 is Reversed in Other Cell Types
Current Cancer Drug Targets 99mTc-(tricine)-HYNIC-Lys-FROP Peptide for Breast Tumor Targeting
Anti-Cancer Agents in Medicinal Chemistry Predictive Factors of Febrile Neutropenia Induced by Anticancer Chemotherapy in the South of Tunisia
Reviews on Recent Clinical Trials